Significance of NMDA receptor-related glutamatergic amino acid levels in peripheral blood of patients with schizophrenia

作者: Tohru Ohnuma , Heii Arai

DOI: 10.1016/J.PNPBP.2010.08.027

关键词:

摘要: Hypo-function of N-methyl d-aspartate (NMDA) receptors is strongly involved in the brain pathophysiology schizophrenia. Several excitatory amino acids, such as endogenous glutamate, glycine, serine and alanine, which are glutamate neurotransmission via NMDA receptors, were studied to further understand schizophrenia find a biological marker for this disease, particularly peripheral blood. In literature review, we connect several earlier clinical studies acid levels blood historical context. Finally, join these results our previous studies, Juntendo University Schizophrenia Projects (JUSP), investigated plasma glutamatergic detail, considered whether may be diagnostic, therapeutic, or symptomatic markers. This review concludes that glycine alanine could schizophrenia, while exogenous augmentation therapies therapeutic Noteworthy d-serine reflect its levels, prove useful diagnostic addition, measurements new molecules, glutathione, promising. future with agents still being examined animal lay foundation development next-generation antipsychotics.

参考文章(116)
Plasma and platelet excitatory amino acids in psychiatric disorders American Journal of Psychiatry. ,vol. 150, pp. 1731- 1733 ,(1993) , 10.1176/AJP.150.11.1731
Daniel C. Javitt, Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia. The Hillside journal of clinical psychiatry. ,vol. 9, pp. 12- 35 ,(1987)
Frank A. Middleton, Karoly Mirnics, Joseph N. Pierri, David A. Lewis, Pat Levitt, Gene Expression Profiling Reveals Alterations of Specific Metabolic Pathways in Schizophrenia The Journal of Neuroscience. ,vol. 22, pp. 2718- 2729 ,(2002) , 10.1523/JNEUROSCI.22-07-02718.2002
D-cycloserine added to clozapine for patients with schizophrenia. American Journal of Psychiatry. ,vol. 153, pp. 1628- 1630 ,(1996) , 10.1176/AJP.153.12.1628
Joseph T. Coyle, I-Ching Tsai, Pinchen Yang, Chung-Wen Tsai, Li-Chen Chung, Guochuan E. Tsai, D-serine added to clozapine for the treatment of schizophrenia. American Journal of Psychiatry. ,vol. 156, pp. 1822- 1825 ,(1999) , 10.1176/AJP.156.11.1822
Tohru Ohnuma, Shosi Tessler, Heii Arai, Richard L.M Faull, Peter J McKenna, Piers C Emson, Gene expression of metabotropic glutamate receptor 5 and excitatory amino acid transporter 2 in the schizophrenic hippocampus Molecular Brain Research. ,vol. 85, pp. 24- 31 ,(2000) , 10.1016/S0169-328X(00)00222-9
Rafiq Waziri, James Wilcox, Arnold D. Sherman, James Mott, Serine metabolism and psychosis Psychiatry Research. ,vol. 12, pp. 121- 136 ,(1984) , 10.1016/0165-1781(84)90012-X
Katsunobu Takahashi, Fumihiko Hayashi, Toru Nishikawa, In Vivo Evidence for the Link Between l‐ and d‐Serine Metabolism in Rat Cerebral Cortex Journal of Neurochemistry. ,vol. 69, pp. 1286- 1290 ,(2002) , 10.1046/J.1471-4159.1997.69031286.X